Duloxetine
Product manufactured by Qpharma Inc
Indications and Purposes
| 1 Indications And Usage Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: • • Major Depressive Disorder [See Clinical Studies (14.1)] • • Generalized Anxiety Disorder [See Clinical Studies ( 14.2 )] • • Diabetic Peripheral Neuropathy [See Clinical Studies ( 14.3 )] • • Chronic Musculoskeletal Pain [See Clinical Studies ( 14.5 )] Duloxetine Delayed-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For: • Major Depressive Disorder (Mdd) ( 1 ) • Generalized Anxiety Disorder (Gad) ( 1 ) • Diabetic Peripheral Neuropathic Pain (Dpnp) ( 1 ) • Chronic Musculoskeletal Pain ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Duloxetine Hydrochloride |
|
ZINC1536779 |